Loading…
Saved in:
Source: | Cardiology and Therapy, Vol 14, Iss 2, Pp 267-282 (2025) |
---|---|
Publisher Information: | Adis, Springer Healthcare, 2025. |
Publication Year: | 2025 |
Subject Terms: | Echocardiography, Mavacamten, Hypertrophic cardiomyopathy, Diseases of the circulatory (Cardiovascular) system, RC666-701 |
Description: |
Abstract Introduction Mavacamten, a cardiac myosin inhibitor, has demonstrated positive outcomes in left ventricular outflow tract (LVOT) gr
|
Database: | Directory of Open Access Journals |